The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 501–600 of 849
Noncoding RNA-mediated regulation of pyroptotic cell death in cancer
Wang, M., Zhang, Y., Chang, W., Zhang, L., Syrigos, K. N., & Li, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1015587 · Cited by 30
NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease
Zhang, J., Zeng, S., Wang, P., Chen, Y., & Zeng, C. (2023) · Current Drug Targets · doi:10.2174/0113894501255960231101105113 · Cited by 25
Jiang, X., Zhong, L., Sun, D., & Rong, L. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.10.009 · Cited by 27
Xiong, Y., Lou, Y., Su, H., Fu, Y., & Kong, J. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.03.003 · Cited by 25
Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Looi, C.-K., Hii, L., Chung, F. F., Mai, C., Lim, W., & Leong, C. (2021) · Cancers · doi:10.3390/cancers13081786 · Cited by 26
Xiao, J., Sun, K., Wang, C., Abu‐Amer, Y., & Mbalaviele, G. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100162 · Cited by 26
Tran, L. S., Ying, L., D’Costa, K., Wray‐McCann, G., Kerr, G., Le, L., Allison, C. C., Ferrand, J., Chaudhry, H., Emery, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39487-1 · Cited by 28
Han, Y., Park, J., Cha, J.-Y., Jeong, M., Go, E., & Hahm, K. B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29956 · Cited by 24
“Defective inflammasome activation led to significant loss of epithelial integrity, more colitis and resulting in colitis-associated carcinogenesis, reaching to conclusion that NLRP3 inflammasome is critically involved in either intestinal homeostasis or rescue from colitis and colitis-associated cancer.(35,36) Thus, t…”
BackgroundDagenais, M., Dupaul-Chicoine, J., Champagne, C., Skeldon, A. M., Morizot, A., & Saleh, M. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.46 · Cited by 26
“In the absence of inflammasome-induced repair, micewith targeted deletion ofCasp1 or Il18, among others, were highly susceptible to AOM–DSS tumorigenesis.(44,47,59) Our results demonstrating that IL-18BP administration toBirc3 / mice abrogated any residual IEC proliferation following AOM injection and one cycle of DSS…”
Role of NLRP3 and NLRP1 inflammasomes signaling pathways in pathogenesis of rheumatoid arthritis
Wang, T., Zhu, C., Wang, S., Mo, L., Yang, G., Hu, J. J., & Zhang, F. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60145-0 · Cited by 25
Inflammatory Bowel Diseases and Inflammasome
Kim, J. M. (2011) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2011.58.6.300 · Cited by 24
“즉, 앞서 IL18 IL18r1 마우스 또는 casp1 마우스 모델을 이용하여 IL-18이 IBD 병인에 방어적으로 작용할 가 능성을 제시한 연구결과들을 소개하였다.(74,75,77,79,80) 그런데 재 조합 IL-18 결합단백 또는 IL-18 항체를 이용한 연구에서 IL-18이 장염발생을 촉진한다는 보고들이 있다.”
InfluentialTargeting inflammasomes as an immunotherapeutic strategy for cancer
Huang, L., Chen, X., Liu, R., Nan, D., Bao, W., Yang, L., Dai, X., Tang, J., Zhang, H., & Lu, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06665-2 · Cited by 28
“At the same time, the lack of the ASC adaptor protein and Caspase-1 promotes disease in mouse models, and the NLRP3 gene in hematopoietic cells demonstrates that the inflammasomes act as attenuators in colitis and CAC [111].”
Li, P., Zhu, N., Wang, D., Zhou, Y., & Liu, Y. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s353380 · Cited by 23
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Mecca, M., Picerno, S., & Cortellino, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052750 · Cited by 31
“Conversely, a reduction or downregulation in several components of the NLRP3 inflammasome has been implicated in the pathogenesis of hepatocellular carcinoma, chemically induced squamous cell carcinoma, primary melanoma, and colitis-associated cancer [240–243].”
BackgroundLi, L., Xu, T., & Qi, X. (2024) · Immunological Reviews · doi:10.1111/imr.13417 · Cited by 27
“161,164 IL-18 also possesses lymphocyte chemotactic properties, plays a crucial role in inducing and promoting proinflammatory mediators and angiogenesis, and regulates the expression of adhesion-related factors involved in CRC tumorigenesis.”
Li, Y., Li, N., Yan, Z., Li, H., Chen, L., Zhang, Z., Fan, G., Xu, K., & Li, Z. (2015) · Hematology · doi:10.1179/1607845415y.0000000029 · Cited by 24
Nod-Like Receptors: Key Molecular Switches in the Conundrum of Cancer
Kent, A., & Blander, J. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00185 · Cited by 27
The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma
Ma, Y., Zhang, G., Li, J., Wang, S., Hu, Z., Zhang, C., & Li, E. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.07.031 · Cited by 22
Yin and yang of tumor inflammation: How innate immune suppressors shape the tumor microenvironments
Jinushi, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28626 · Cited by 24
“For example, MDSC-derived IL-1b creates protumorigenic inflammation and a chemoresistant niche by facilitating the differentiation of proangiogenic IL-17producing CD41 T cells, and the tolerogenic cell death induced by gemcitabine or 5-fluorouracil supports the production of pro-tumorigenic IL-1b from MDCSs.37,38 Auto…”
BackgroundRodent Intestinal Epithelial Carcinogenesis: Pathology and Preclinical Models
Ward, J. M., & Treuting, P. M. (2013) · Toxicologic Pathology · doi:10.1177/0192623313505156 · Cited by 25
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis
Chen, J., Singh, N., Ye, X., Theune, E. V., & Wang, K. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00796-2 · Cited by 24
Wang, P., Gu, Y., Yang, J., Qiu, J., Xu, Y., Xu, Z., Gao, J., & Wan, C. (2022) · Aging · doi:10.18632/aging.204438 · Cited by 23
“However, NLRP3 functions as a tumor suppressor and protects against colitis-associated cancer [27].”
Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3
Kim, J., Kim, H. K., Lee, J., Jang, S., Cho, E., Mun, S., Yoon, S., & Yang, C. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00971-1 · Cited by 25
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Hreich, S. J. D., Hofman, P. M., & Vouret‐Craviari, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119235 · Cited by 21
“In AOM/DSS-induced colon cancer, it has been shown that IL-18 levels were decreased in tumor-bearing mice [95], that the NLRP3/ASC/CASP1/IL-18 axis was important to dampen tumor growth [95,96] and this was dependent on IFN-γ production [97].”
BackgroundBarsoumian, H. B., He, K., Hsu, E. Y., Bertolet, G., Sezen, D., Hu, Y. Y., Riad, T. S., Cortez, M. A., & Welsh, J. W. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03471-x · Cited by 23
The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
Wang, W., Zhang, Y., Yang, L., & Li, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.004 · Cited by 22
Ringel-Scaia, V. M., Qin, Y., Thomas, C. A., Huie, K. E., McDaniel, D. K., Eden, K. B., Wade, P. A., & Allen, I. C. (2019) · Journal of Innate Immunity · doi:10.1159/000495850 · Cited by 24
Self-citationManipulation of Inflammasome: A Promising Approach Towards Immunotherapy of Lung Cancer
Sarkar, R. D., Sinha, S., & Biswas, N. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1876044 · Cited by 21
“One study showed an anti-tumorigenic role in colitis-associated cancer whereas another study using the same model showed no effect of NLRC4 on cancer progression [65,66].”
ResultMao, X., Liu, S., Ge, L., Du, H., Yue, D., Hou, L., Huang, K., & Chen, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c03025 · Cited by 21
Asaba, C. N., Hameed, S. A., Agyei, E. K., Jacob, J. C., Oyebanji, V. O., & Ekabe, C. J. (2022) · Journal of Immunology Research · doi:10.1155/2022/7883945 · Cited by 25
“to describe the role of NF-κB in persistent inflammatory cycle leading to cancer, numerous studies have elucidated the role of chronic inflammation and mechanisms by which cancer develops in these environments [192, 193].”
Li, G. Q., Gao, S. X., Wang, F. H., Kang, L., Tang, Z. Y., & Xiao, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115019 · Cited by 26
Zhao, H., Zhang, L., Du, D., Mai, L., Liu, Y., Morigen, M., & Fan, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113195 · Cited by 25
Review: New Anti-Cytokines for IBD: What is in the Pipeline?
Scharl, M. M., Vavricka, S. R., & Rogler, G. (2013) · Current Drug Targets · doi:10.2174/13894501113149990159 · Cited by 22
Song, W., Liu, Z., Wang, K., Tan, K., Zhao, A., Li, X., Yuan, Y., & Yang, Z. (2022) · Discover Oncology · doi:10.1007/s12672-022-00495-0 · Cited by 20
Chen, K., Shanmugam, N. K. N., Pazos, M. A., Hurley, B. P., & Cherayil, B. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160937 · Cited by 21
Kitazawa, M., Hida, S., Fujii, C., Taniguchi, S., Ito, K., Matsumura, T., Okada, N., Sakaizawa, T., Kobayashi, A., Takeoka, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169340 · Cited by 19
“Colorectal cancer was enhanced upon genetic deletion of caspase-1 or ASC [14], while ASC-overexpressing lymphoma cells showed reduced metastasis [15].”
BackgroundStress-Induced NLRP3 Inflammasome in Human Diseases
Alcocer‐Gómez, E., Castejón‐Vega, B., & Cordero, M. D. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.02.002 · Cited by 21
Inflammasomes and intestinal tumorigenesis
Zaki, H., Lamkanfi, M., & Kanneganti, T. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.11.003 · Cited by 21
“Nevertheless, NLRP3 was consistently found to be a weaker regulator of tumor development relative to caspase-1 and ASC as both Asc-knockout (KO) mice and caspase-1–KO mice suffered from increased colorectal tumorigenesis [24, 32].”
BackgroundInfluentialAdachi, S., Hoshi, N., Inoue, J., Yasutomi, E., Otsuka, T., Dhakhwa, R., Wang, Z., Koo, Y., Takamatsu, T., Matsumura, Y., et al. (2017) · International Archives of Allergy and Immunology · doi:10.1159/000471923 · Cited by 20
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
Zhou, H., Zhang, L., Luo, W., Hong, H., Tang, D., Zhou, D., Zhou, L., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1050774 · Cited by 21
“, 2019), inflammasome and IL-1β-mediated antitumor activity have also been demonstrated in NPC and hematopoietic cells, consistent with our foundings (Ghiringhelli et al., 2009; Allen et al., 2010; Chen et al., 2012).”
BackgroundResultZhang, C., Xia, J., Liu, X., Li, Z., Gao, T., Zhou, T. G., & Hu, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-45005-6 · Cited by 23
“Furthermore, investigators have demonstrated the inhibitory effect of NLR inflammasomes in colitis-associated cancer using an animal model lacking the NLRC4 inflammasome components 61 .”
BackgroundDomblides, C., Crampton, S., Liu, H., Bartleson, J. M., Nguyen, A., Champagne, C., Landy, E., Spiker, L., Proffitt, C., Bhattarai, S., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci166085 · Cited by 18
“Another study using AOM/DSS showed no difference in Nlrc4 –/– mice (26).”
Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy
Li, L., Chen, L., & Sun, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122951 · Cited by 21
Using high-throughput sequencing to explore the anti-inflammatory effects of α-mangostin
Yin, P., Zou, W., Li, J., Jin, N., Gao, Q., & Liu, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-52036-5 · Cited by 18
Lee, C., Hung, P.-F., Lu, S.-C., Chung, H.-L., Chiang, S., Wu, C., Chou, W., & Sun, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236101 · Cited by 18
Rosenberg, A. F., Fan, H., Chiu, Y. G., Bolce, R. J., Tabechian, D., Barrett, R., Moorehead, S., Baribaud, F., Liu, H., Peffer, N. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110657 · Cited by 19
“In Ps, CD14 cells, AR met the significance threshold while in CD14(2) cells, RORC, a transcription factor in Th17 cells [43], NR3C1, a glucocorticoid gene with polymorphisms linked to obesity, hypertension, elevated lipid levels and increased cardiovascular risk [44], and PYCARD-an adaptor protein for NLRP3 the inflam…”
BackgroundSerrya, M. S., El‐Sheakh, A. R., & Makled, M. N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119154 · Cited by 20
Morciano, G., Pellielo, G., Agyapong, E. D., Pellegrino, C., Patergnani, S., Franceschini, D., Koutsikos, K., Rigon, L., Pinton, P., & Rimessi, A. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07783-1 · Cited by 20
“Although the release of same cytokines, NLRP3 may also participate in epithelial regeneration in specific contexts, suggesting that the inflammasome, in gastro-intestinal apparatus, may have dual and controversial roles [274].”
Mattiola, I., & Diefenbach, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101724 · Cited by 19
Zhang, H., Zhang, J., Luan, S., Liu, Z., Li, X., Liu, B., & Yuan, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85753 · Cited by 17
Pan, W., Jia, Z., Du, J., Chang, K., Liu, Y., Liu, W., Zhao, X., & Tan, W. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s495564 · Cited by 18
“11 NLRP3 inflammasome has a dual role in tumors, 7 with protective roles in hepato-cellular and colorectal carcinoma, 12,13 that lower NLRP3 levels are associated with poorer prognosis and higher morbidity.”
Emerging Role of Mitophagy in Inflammatory Diseases: Cellular and Molecular Episodes
Adil, A. M., Ameenudeen, S., Kumar, A., Hemalatha, S., Ahmed, N., Ali, N., Alasmari, A. F., Aashique, M., & Waseem, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200107144810 · Cited by 18
Lang, W., Cheng, M., Zheng, X., Zhao, Y., Qu, Y., Jia, Z., Gong, H., Ali, I., Tang, J., & Zhang, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108466 · Cited by 17
Fan, W., Gao, X., Ding, C., Lv, Y., Shen, T., Ma, G., Yan, L., & Song, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.085 · Cited by 18
Generation of Bone Marrow and Fetal Liver Chimeric Mice
Holl, E. K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-496-8_24 · Cited by 17
“Reconstitution of lethally irradiated mice can be conducted using cells obtained from (a) bone marrow of adult donor mice [6] and (b) fetal liver cells obtained from embryonic day 14 (E14) mouse fetuses [7].”
BackgroundSelf-citationRegulation of cancer by inflammasomes: from inflammation to tumorigenesis
Malvankar, S., Jaiswal, P., Bhat, P. P., & Mehto, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1611719 · Cited by 19
Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis
Lei, K., Chen, J., Deng, Y., Peng, Y., Zhai, X., Ren, X., Zhao, J., Chen, B., & Jiang, C. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03569-3 · Cited by 19
“NLRP3 inflammasomes protect colonic mucosa during acute colitis, and their deficiency exacerbates chemically induced colitis-associated CRC [87, 88].”
Regulation of NLRP3/TRIM family signaling in gut inflammation and colorectal cancer
Mohapatra, B. S., Lavudi, K., Kokkanti, R. R., & Patnaik, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189271 · Cited by 17
Lozano‐Gil, J. M., Rodríguez‐Ruiz, L., Tyrkalska, S. D., García‐Moreno, D., Pérez‐Oliva, A. B., & Mulero, V. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104404 · Cited by 19
Zeng, Y., Cai, Y., Chai, P., Mao, Y., Chen, Y., Wang, L., Zeng, K., Zhan, Z., Xie, Y., Li, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961933 · Cited by 20
“However, disease progression was not diminished in NLRC4-deletion mice (75).”
BackgroundTherapeutic effect of Captopril on rheumatoid arthritis in rats
Liu, H., & Wang, R. C. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60175-9 · Cited by 17
Guey, B., Bodnar‐Wachtel, M., Drouillard, A., Eberhardt, A., Pratviel, M., Goutagny, N., Bendriss‐Vermare, N., Puisieux, I., Caux, C., Walzer, T., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01683 · Cited by 20
GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14
Liu, Q., Jiao, L., Ye, M.-S., Ma, Z., Yu, J., Su, L., Zou, W.-Y., Yang, L.-X., Chen, C., & Yao, Y. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01155-9 · Cited by 15
Awwad, S. F., Assaf, R., Emam, A. A., Fouad, A., Arafa, L. F., & El-Hanafy, A. A. (2023) · Medical Oncology · doi:10.1007/s12032-022-01945-z · Cited by 16
Pyroptosis, Metabolism, and Oxidation in Tumorigenesis: Mechanisms and Therapeutic Implications
Cao, Q., Zhang, J., Sun, D.-Y., Fu, J., Wu, W., Chen, X., Li, D., & Wang, P. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0257 · Cited by 18
Jenkins, B. J. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0081 · Cited by 17
Deswaerte, V., Ruwanpura, S. M., & Jenkins, B. J. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.09.023 · Cited by 15
SR-A1 suppresses colon inflammation and tumorigenesis through negative regulation of NF-κB signaling
Zong, G., Zhu, Y., Zhang, Y., Wang, Y., Bai, H., Yang, Q., Ben, J., Zhang, H., Li, X., Zhu, X., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.017 · Cited by 15
Environmental Factors Modify the Severity of Acute DSS Colitis in Caspase-11-Deficient Mice
Fan, T., Tchaptchet, S., Arsene, D., Mishima, Y., Liu, B., Sartor, R. B., Carroll, I. M., Miao, E. A., Fodor, A. A., & Hansen, J. J. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy244 · Cited by 15
Damage control: Management of cellular stress by the NLRP 3 inflammasome
Haasken, S., & Sutterwala, F. S. (2013) · European Journal of Immunology · doi:10.1002/eji.201343848 · Cited by 16
Iida, T., Hirayama, D., Minami, N., Matsuura, M., Wagatsuma, K., Kawakami, K., Nagaishi, K., Nojima, M., Ikeuchi, H., Hirota, S., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.10.003 · Cited by 16
“Therefore, the expression of RalGAPa2 decreased, that is, activation of Ral was observed at a more advanced stage in CAC.”
BackgroundInfluentialTRIMs: Generalists Regulating the NLRP3 Inflammasome Signaling Pathway
Deng, N.-H., Zhou, Z., Liu, H., Tian, Z., Wu, Z.-F., Liu, X.-Y., Xiong, W., Zuo, W., & Jiang, Z.-S. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.0943 · Cited by 14
“However, since NLRP3 has a protective role in inflammatory bowel disease models (Allen et al. , 2010), as opposed to the previous one, deficiency of TRIM31 could, in turn, to some extent attenuate the severity of dextran sodium sulfate-induced colitis.”
Ning, Y., Lin, K., Fang, J., Chen, X., Hu, X., Liu, L., Zhao, Q., Wang, H., & Wang, F. (2023) · Journal of Immunology Research · doi:10.1155/2023/7040113 · Cited by 17
“Previous studies showed that the inflammasome components provide protection against the development of colon cancer in the CAC model [56, 57].”
BackgroundInflammasomes as regulators of non-infectious disease
Okin, D. A., & Kagan, J. C. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101815 · Cited by 14
Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy
Li, Z., Rana, I., Park, G. T., Lee, J., Park, C. E., & Nam, J. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00633-y · Cited by 14
“The representative CLRs utilized for cancer immunotherapy activation in some other cases, suggesting a complex role of NLRs in antitumor immunity and tumorigenesis (da Silva Correia et al. 2006; Chen et al. 2008; Allen et al. 2010, 2012; Chan et al. 2016; Li et al. 2018; Jiang et al. 2020).”
BackgroundWang, P., Tang, C., Li, J., Huang, X., Jin, R., Yin, F., Liu, Z., Chen, Y., & Zeng, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111194 · Cited by 17
Morrison, H. A., Eden, K. B., Trusiano, B., Rothschild, D. E., Qin, Y., Wade, P. A., Rowe, A., Mounzer, C., Stephens, M. C., Hanson, K. M., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.05.004 · Cited by 15
Self-citationHsu, C., Mustafa, M. A., Omar, T. M., Taher, S. G., Ubaid, M., Gilmanova, N. S., Abdulraheem, M. N., Saadh, M. J., Athab, A. H., Mirzaei, R., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1396789 · Cited by 23
“Mice with NLRP3 deficiency are more likely to develop experimental colitis (209–211); this vulnerability might be reversed by administering exogenous IL-1 β or IL-18 (207).”
BackgroundThe Role of Inflammasome-Associated Innate Immune Receptors in Cancer
Dawson, R., & Jenkins, B. J. (2024) · Immune Network · doi:10.4110/in.2024.24.e38 · Cited by 16
“Indeed, this is highlighted by another study using Nlrp3 −/− mice (from a different laboratory to that of Allen et al. (99)) reporting that genetic ablation of NLRP3 in mice had no effect on AOM/ DSS-induced CAC (104).”
BackgroundResultInfluentialInterleukin-1 signaling in solid organ malignancies
Dosch, A. R., Singh, S. P., Nagathihalli, N. S., Datta, J., & Merchant, N. B. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188670 · Cited by 15
Cambui, R. A. G., Fernandes, F. P., Leal, V. N. C., dos Reis, E. C., de Lima, D. S., Santo, G. F. D. E., Elias, R. M., & Pontillo, A. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04284-8 · Cited by 14
“Currently, either a beneficial (Allen et al. 2010; Zaki et al. 2010; Dupaul-Chicoine et al. 2015) and a detrimental (Huber et al.”
Backgroundp16INK4a Plays Critical Role in Exacerbating Inflammaging in High Fat Diet Induced Skin
Liang, Y., Gu, T., Peng, S., Lin, Y., Liu, J., Wang, X., Huang, X., Zhang, X., Zhu, J., Zhao, L., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3415528 · Cited by 17
“Previous studies have also shown that NLRC4 is involved in tumor progression, including breast cancer and colitis-associated cancer [42, 43].”
Holding the inflammatory system in check: NLRs keep it cool
Jha, S., & Ting, J. P.-Y. (2015) · F1000Prime Reports · doi:10.12703/p7-15 · Cited by 17
“NLRP3 serves as a checkpoint for the prevention of CAC development in this model [81,82].”
BackgroundSelf-citationThe role of NLRP3 and NLRP12 inflammasomes in glioblastoma
Rajkhowa, S., & Jha, S. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00309-z · Cited by 14
Innate Immunity Never “NODs” Off: NLRs Regulate the Host Anti‐Viral Immune Response
Woolls, M. K., Mott, M., Poole, C. S., Gregory, J. A., Ivester, H. M., & Allen, I. C. (2025) · Immunological Reviews · doi:10.1111/imr.13429 · Cited by 15
Self-citationInterleukin-1β and cancer immune response
Rébé, C., & Ghiringhelli, F. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.102002 · Cited by 15
Whetstone, R. D., Wittel, U. A., Michels, N. M., Gulizia, J. M., & Gold, B. I. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22361 · Cited by 15
Zhang, F., Zhao, W., Zhou, J., Wang, W., Luo, J., Feng, Y., Wu, J., Li, M., Wang, K., Niu, J., et al. (2020) · Gene · doi:10.1016/j.gene.2020.145299 · Cited by 15
Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021
Zhang, T., Zhang, B., Tian, W., Wang, F., Zhang, J., Ma, X., Wei, Y., & Tang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.951004 · Cited by 14
The Role and Therapeutic Potential of Pyroptosis in Colorectal Cancer: A Review
Fang, Q. Z., Xu, Y., Tan, X., Wu, X., Li, S., Yuan, J., Chen, X., Huang, Q., Fu, K., & Xiao, S. (2024) · Biomolecules · doi:10.3390/biom14070874 · Cited by 14
“Several studies have identified the anti-tumor effects of pyroptosis in CRC [18,122,123].”
BackgroundJain, T., Chandra, A., Mishra, S. P., Khairnar, M., Rajoria, S., Maheswari, R. U., Keerthika, R., Tiwari, S., & Agrawal, R. (2024) · Head and Neck Pathology · doi:10.1007/s12105-024-01685-8 · Cited by 12
“However, Allen et al. found it as a negative regulator of tumorigenesis in colitis-associated cancer [13 ].”
Maeda, T., Shirakami, Y., Taguchi, D., Miwa, T., Kubota, M., Sakai, H., Ibuka, T., Mori, K., Tomita, H., & Shimizu, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111640 · Cited by 13
“In contrast to the present study, previous reports have indicated that NLRP3 deficiency leads to colorectal tumor progression [12,17].”
ResultNLRP3 inflammasome: From drug target to drug discovery
Yin, L., Zhang, H., Shang, Y., Wu, S., & Jin, T. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104375 · Cited by 15
Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer
Tahmasebi, S., Alimohammadi, M., Khorasani, S., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00749-0_25 · Cited by 21
Liu, J., Yang, X., Zhang, L., Yang, B., Rao, W., Li, M., Dai, N., Yang, Y., Qian, C., Zhang, L., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03287-7 · Cited by 15
West, A. J., Deswaerte, V., West, A. C., Gearing, L. J., Tan, P. B. O., & Jenkins, B. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.830350 · Cited by 12
“Frontiers in Oncology | www.frontiersin.org March 2022 | Volume 12 | Article 83035010 induced colitis-associated colon cancer (CAC) (27, 36).”
BackgroundInfluentialZaharie, R. D., Vălean, D., Popa, C., Fetti, A. C., Zdrehuş, C., Puia, A., Usatiuc, L. O., Schlanger, D., & Zaharie, F. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043472 · Cited by 12
The cytosolic DNA sensor AIM2 promotes Helicobacter‐induced gastric pathology via the inflammasome
Dawson, R., Deswaerte, V., West, A. C., Sun, E., Wray‐McCann, G., Livis, T., Kumar, B., Rodriguez, E., Gabay, C., Ferrero, R. L., et al. (2023) · Immunology and Cell Biology · doi:10.1111/imcb.12641 · Cited by 13
Signal‐transducing innate receptors in tumor immunity
Hangai, S., Kimura, Y., Taniguchi, T., & Yanai, H. (2021) · Cancer Science · doi:10.1111/cas.14848 · Cited by 14
ASC deficiency suppresses proliferation and prevents medulloblastoma incidence
Knight, E. R. W., Patel, E., Flowers, C., Crowther, A., Ting, J. P. ‐., Miller, C. R., Gershon, T. R., & Deshmukh, M. (2014) · Oncogene · doi:10.1038/onc.2013.577 · Cited by 12
Self-citation
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.